BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28613942)

  • 21. Medullary thyroid carcinoma in children.
    Viola D; Romei C; Elisei R
    Endocr Dev; 2014; 26():202-13. PubMed ID: 25231454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
    Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple endocrine neoplasia type 2.
    Peczkowska M; Januszewicz A
    Fam Cancer; 2005; 4(1):25-36. PubMed ID: 15883707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
    Sansó G; Domené HM; Iorcansky S; Barontini M
    Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2B map to the same region of chromosome 10 as multiple endocrine neoplasia type 2A.
    Lairmore TC; Howe JR; Korte JA; Dilley WG; Aine L; Aine E; Wells SA; Donis-Keller H
    Genomics; 1991 Jan; 9(1):181-92. PubMed ID: 1672289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution of RET Mutations and Evaluation of Treatment Approaches in Hereditary Medullary Thyroid Carcinoma in Turkey.
    Aydoğan Bİ; Yüksel B; Tuna MM; Navdar Başaran M; Akkurt Kocaeli A; Ertörer ME; Aydın K; Güldiken S; Şimşek Y; Cihan Karaca Z; Yılmaz M; Aktürk M; Anaforoğlu İ; Kebapçı N; Duran C; Taşlıpınar A; Kulaksızoğlu M; Gürsoy A; Dağdelen S; Erdoğan MF
    J Clin Res Pediatr Endocrinol; 2016 Mar; 8(1):13-20. PubMed ID: 26758973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medullary carcinoma of the thyroid gland and the MEN 2 syndromes.
    Skinner MA; Wells SA
    Semin Pediatr Surg; 1997 Aug; 6(3):134-40. PubMed ID: 9263335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RET mutation status in medullary thyroid cancer(MTC) patients and the significance of genetic screening for mutations in their immediate relatives--a preliminary report.
    Menon MM; Simha MR
    Indian J Pathol Microbiol; 2005 Apr; 48(2):161-5. PubMed ID: 16758654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B.
    O'Riordain DS; O'Brien T; Weaver AL; Gharib H; Hay ID; Grant CS; van Heerden JA
    Surgery; 1994 Dec; 116(6):1017-23. PubMed ID: 7985081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetics of Multiple Endocrine Neoplasia Type 1/Multiple Endocrine Neoplasia Type 2 Syndromes.
    Hyde SM; Cote GJ; Grubbs EG
    Endocrinol Metab Clin North Am; 2017 Jun; 46(2):491-502. PubMed ID: 28476233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic testing for familial cancer. Consequences of RET proto-oncogene mutation analysis in multiple endocrine neoplasia, type 2.
    Learoyd DL; Marsh DJ; Richardson AL; Twigg SM; Delbridge L; Robinson BG
    Arch Surg; 1997 Sep; 132(9):1022-5. PubMed ID: 9301617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RET oncogene mutations in medullary thyroid carcinoma in Mexican families.
    González B; Salcedo M; Medrano ME; Mantilla A; Quiñónez G; Benítez-Bribiesca L; Rodríguez-Cuevas S; Cabrera L; de León B; Altamirano N; Tapia J; Dawson B
    Arch Med Res; 2003; 34(1):41-9. PubMed ID: 12604374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic testing in endocrinology: lessons learned from experience with multiple endocrine neoplasia type 2 (MEN2).
    Jimenez C; Gagel RF
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S150-7. PubMed ID: 15135800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genotype-phenotype relationship in multiple endocrine neoplasia type 2. Implications for clinical management.
    Raue F; Frank-Raue K
    Hormones (Athens); 2009; 8(1):23-8. PubMed ID: 19269918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A nationwide clinical survey of patients with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma in Japan.
    Iihara M; Yamashita T; Okamoto T; Kanbe M; Yamazaki K; Egawa S; Yamaguchi K; Obara T
    Jpn J Clin Oncol; 1997 Jun; 27(3):128-34. PubMed ID: 9255265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endocrine surgical aspects of multiple endocrine neoplasia syndromes in children.
    Harrison B
    Horm Res; 2007; 68 Suppl 5():105-6. PubMed ID: 18174722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic screening of endocrine tumour syndromes with DNA probes: the example of medullary thyroid carcinoma.
    Sobol H; Narod SA; Assouline D; Lenoir GM
    Horm Res; 1989; 32(1-3):34-40. PubMed ID: 2575577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma.
    Krampitz GW; Norton JA
    Cancer; 2014 Jul; 120(13):1920-31. PubMed ID: 24699901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medullary thyroid carcinoma and multiple endocrine neoplasia type 2.
    Takami H
    Endocr Pathol; 2003; 14(2):123-31. PubMed ID: 12858002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The molecular genetics of multiple endocrine neoplasia type 2A and related syndromes.
    Moley JF
    Annu Rev Med; 1997; 48():409-20. PubMed ID: 9046972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.